Improved survival in Medicare patients with multiple myeloma: findings from a large nationwide and population-based cohort
Sign Up to like & getrecommendations! Published in 2017 at "Medical Oncology"
DOI: 10.1007/s12032-017-1001-7
Abstract: The aim of this study was to examine whether novel agents proteasome inhibitor bortezomib and immunomodulatory drugs lenalidomide and thalidomide are effective in prolonging overall survival (OS) for patients with newly diagnosed multiple myeloma (MM)… read more here.
Keywords: nationwide population; population based; cases 2005; multiple myeloma ... See more keywords